Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function
- 12 May 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (19) , 8049-8054
- https://doi.org/10.1073/pnas.0900149106
Abstract
Class B1 (secretin family) G protein-coupled receptors (GPCRs) modulate a wide range of physiological functions, including glucose homeostasis, feeding behavior, fat deposition, bone remodeling, and vascular contractility. Endogenous peptide ligands for these GPCRs are of intermediate length (27–44 aa) and include receptor affinity (C-terminal) as well as receptor activation (N-terminal) domains. We have developed a technology in which a peptide ligand tethered to the cell membrane selectively modulates corresponding class B1 GPCR-mediated signaling. The engineered cDNA constructs encode a single protein composed of (i) a transmembrane domain (TMD) with an intracellular C terminus, (ii) a poly(asparagine-glycine) linker extending from the TMD into the extracellular space, and (iii) a class B1 receptor ligand positioned at the N terminus. We demonstrate that membrane-tethered peptides, like corresponding soluble ligands, trigger dose-dependent receptor activation. The broad applicability of this approach is illustrated by experiments using tethered versions of 7 mammalian endogenous class B1 GPCR agonists. In parallel, we carried out mutational studies focused primarily on incretin ligands of the glucagon-like peptide-1 receptor. These experiments suggest that tethered ligand activity is conferred in large part by the N-terminal domain of the peptide hormone. Follow-up studies revealed that interconversion of tethered agonists and antagonists can be achieved with the introduction of selected point mutations. Such complementary receptor modulators provide important new tools for probing receptor structure–function relationships as well as for future studies aimed at dissecting the tissue-specific biological role of a GPCR in vivo (e.g., in the brain vs. in the periphery).Keywords
This publication has 35 references indexed in Scilit:
- Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1Journal of Biological Chemistry, 2008
- Class-B GPCR activation: is ligand helix-capping the key?Trends in Biochemical Sciences, 2008
- Teduglutide in intestinal adaptation and repair: light at the end of the tunnelExpert Opinion on Investigational Drugs, 2008
- Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular DomainJournal of Biological Chemistry, 2008
- Molecular recognition of parathyroid hormone by its G protein-coupled receptorProceedings of the National Academy of Sciences, 2008
- Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptorProceedings of the National Academy of Sciences, 2007
- Identification of Amino Acid Determinants of Dopamine 2 Receptor Synthetic Agonist FunctionThe Journal of Pharmacology and Experimental Therapeutics, 2007
- CRF signaling: molecular specificity for drug targeting in the CNSTrends in Pharmacological Sciences, 2006
- In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptideLife Sciences, 2004
- Synergistic Contributions of the Functional Groups of Epinephrine to Its Affinity and Efficacy at the β2 Adrenergic ReceptorMolecular Pharmacology, 2004